Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | MicrobiomeTrials← Back to trialsNCT04844866
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-08-18Est. Completion: 2025-01-15
Enrollment target: 213 participants Locations- LKH - Medizinische Universitaet Graz, Graz, Austria
- Universitatsklinikum Innsbruck Universitatsklinik fur Innere Medizin V, Innsbruck, Austria
- Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria
- Medizinische Universitaet Wien - Allgemeines Krankenhaus der Stadt Wien (AKH), Vienna, Austria
- Jules Bordet lnstitute, Anderlecht, Belgium
- Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium
- University Hospital Center Zagreb, Zagreb, Croatia
- University Hospital Hradec Kralove, Hradec Králové, Czechia
- FNsP Ostrava, Ostrava, Czechia
- Helsinki University Comprehensive Cancer Center, Helsinki, Finland
- Oulu University Central Hospital, Oulu, Finland
- Turku University Hospital, Turku, Finland
- Centre Hospitalier Universitaire (CHU) - Hopital Henri Mondor, Créteil, France
- CHRU de Lille - Hopital Claude Huriez, Lille, France
- Centre Hospitalier Lyon Sud, Hospices Civils de Lyon Groupement Hospitalier Sud, Lyon, France
- Centre Paoli Calmettes, Marseille, France
Other microbiome trials you might be interested in
DLBCL - Diffuse Large B Cell Lymphoma
This study will ultimately aim at providing the scientific community with patient-reported health status data that will …
Bologna, ItalyCompleted Feb 15, 2024
Mantle Cell Lymphoma (MCL)Diffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma ( FL)Waldenström Macroglobulinemia (WM)Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
BTK inhibitors and BCL-2 inhibitors have demonstrated significant clinical activity in mature B-cell malignancies, and c…
Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hopital Hotel Dieu, Nantes, FranceCentre Hospitalier Universitaire de Bordeaux - Hopital Haut-Leveque, Pessac, FranceCentre Hospitalier Universitaire de Poitiers, Poitiers, FranceInstitut Universitaire du Cancer Service d´hématologie, Toulouse, FranceCHU de Nancy Hopitaux de Brabois, Vandœuvre-lès-Nancy, FranceUniversitatsklinikum Augsburg, Augsburg, GermanyUniversitaetsklinikum Knappschaftskrankenhaus Bochum der Ruhr-Universitat Bochum, Bochum, GermanyUniversitaetsklinikum Koeln, Cologne, GermanyKlinikum Erlangen der Friedrich-Alexander-Universitaet Erlangen-Nuernberg, Erlangen, GermanyUniversitaetsklinikum Essen, Essen, GermanyUniversity Medical Center Hamburg-Eppendorf, Hamburg, GermanyUniversitaetsklinikum Heidelberg, Heidelberg, GermanyUniversitätsklinikum Leipzig, Leipzig, GermanyKlinikum der Universitat München, Studienzentrale fur Hematologie der Medizinischen Klinik II, München, GermanyUniversity Hospital Regensburg, Regensburg, GermanyUniversity Hospital of Tuebingen, Tübingen, GermanyDel-Pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, HungaryDebreceni Egyetem - Orvos es Egeszsegtudomanyi Centrum (DEOEC) (University of Debrecen Medical and Health Science Center), Debrecen, HungaryAzienda Ospedaliera San Giovanni Battista Di Torino, Torino, ItalyAmsterdam Universitaire Medische Centra (UMC) - locatie Amsterdam Medisch Centrum (AMC), Amsterdam, NetherlandsUniversity Medical Center Groningen, Groningen, NetherlandsLeiden University Medical Center (LUMC), Leiden, NetherlandsErasmus University Medical Center, Rotterdam, NetherlandsUniwersytecki Szpital Kliniczny - Klinika Hematologii, Terapii Komorkowych i Chorob Wewnetrznych, Wroclaw, PolandInstituto Portugues de Oncologia do Porto Francisco Gentil E.P.E, Porto, PortugalHospital Universitari Vall d'Hebron, Barcelona, SpainHospital Clinic de Barcelona (Hospital Clinic i Provincial), Barcelona, SpainCatalan Institute of Oncology (ICO) Hospitalet, Barcelona, SpainHospital Clínico San Carlos (HCSC), Madrid, SpainHospital Universitario Virgen De La Arrixaca (Huva), Murcia, SpainClinica Universidad de Navarra, Pamplona, SpainHospital Clinico Universitario de Salamanca, Salamanca, SpainDr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey (Türkiye)American Hospital, Şişli, Turkey (Türkiye)Koc Universitesi Hastanesi (Koc University Hospital), Zeytinburnu, Turkey (Türkiye)Multiple Locations
Est. completion Jun 30, 2029
Diffuse Large B Cell Lymphoma RefractoryDiffuse Large B Cell Lymphoma RelapsedEpstein-Barr Virus (EBV) Infection
This is a Phase Ib in adult patients with relapsed or refractory EBV-positive DLBCL using daily oral dosing of VK-2019 i…
Lexington, United StatesEst. completion Oct 1, 2028